As healthcare providers, we are dedicated to patient care and safety. A critical aspect of this is preventing hospital-acquired infections (HAIs), which can lead to significant morbidity, mortality, and financial burden on the healthcare system.
HAIs are infections patients acquire while receiving treatment for other conditions. They affect approximately 1 in 31 hospital patients in the United States. The most common types include pneumonia, surgical site infections, gastrointestinal infections, urinary tract infections, and bloodstream infections.
Prevention strategies are multifaceted and should be tailored to the specific type of HAI. General strategies include hand hygiene, use of personal protective equipment, sterilization of equipment, and environmental cleaning. Adherence to these practices is crucial in reducing the incidence of HAIs.
Treatment involves identifying the causative organism through microbiological testing and providing appropriate antimicrobial therapy. In some cases, surgical intervention may be necessary to remove infected tissue or devices. It is essential to monitor patients closely for signs of infection and intervene promptly.
Antimicrobial stewardship programs play a key role in preventing the emergence of antimicrobial resistance, a significant concern with HAIs. These programs promote the appropriate use of antimicrobials, including selection, dosing, route, and duration of therapy.
Preventing and managing HAIs is a critical aspect of patient care. It requires a comprehensive approach that includes adherence to infection prevention practices, prompt identification and treatment of infections, and effective antimicrobial stewardship. By understanding and addressing these aspects, we can significantly reduce the burden of HAIs and improve patient outcomes.
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
New imaging guidelines for head and neck cancers, a step toward practice change
4.
How wildfires pose challenges to cancer care
5.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
3.
Geriatric Medicine Through Long-Term Functional Survivorship After Cancer in Older Adults
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Advanced Directions in Oncology and Quality Improvement
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
When Unexplained Bruising May Require Blood Testing
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation